Back to Article:

Drug Plan Trends Report: A snapshot of what’s coming down the pike

Add a comment

Have your say on this topic! Comments that are thought to be disrespectful or offensive may be removed by our Benefits Canada admins. Thanks!

* These fields are required.
Field required
Field required
Field required
Comments

wayne parkinson:

why has health Canada not approved prometic life sciences ryplazim.stop waiting for the fda to aepprov first , they don’t care about people ,just American companies. get it done.

Friday, May 04 at 12:14 pm | Reply

Join us on Twitter